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1. Introduction 
Radiations exist ubiquitously in the environment since the Earth's creation in soil, water and 
plants. Radiation exposure is a concern in the health industry and other occupations in the 
world. Apart from diagnostic, therapeutic and industrial purposes, humans also are 
exposed to ionizing radiations during air and space travel and exploration, background 
radiation, nuclear accidents, and nuclear terror attacks. Elevated radiation levels have been 
detected following Chernobyl on April 1986 at Ukraine, and recently Fukushima Daiichi 
Nuclear Power Plants on March 2011 at Japan. This raised the need for finding out efficient 
and reliable radioprotectors especially when a whole nation is exposed at high or even low 
levels for a prolonged period. The fallout and radioactivity cause concern during the weeks 
and months after the accidents. In addition, radiations are commonly used in a number of 
medical and industrial situations; however, their pro-oxidative effects limit their 
applications. Therefore, it is essential to protect humans from ionizing radiations by efficient 
pharmacological intervention. A valid approach to halt normal tissue radiotoxicity is the use 
of radioprotectors that when present prior to radiation exposure protect normal tissues from 
radiation effects. This view has also been used as a successful preventative measure for 
possible nuclear/radiological situation. From a practical point of view radioprotectors 
should perfectly have several criteria that relate to the ability of the agent to improve the 
therapeutic outcome. Ionizing radiation causes oxidative damage to tissues within an 
extremely short period, and possible protection against it would require the rapid transfer of 
smart antioxidants to the sensitive sites in cells. At this point, melatonin (N-acetyl-5-
methoxytryptamine; MW= 232), an innate antioxidant produced mainly by the pineal gland, 
seems unique among antioxidants because of its multiple properties and reactions which 
reviewed and documented in several publications and summarised herein.  
While ionizing radiation exposures, due to free radical generation, present an enormous 
challenge for biological and medical safety, melatonin is a potent radioprpotector. In several 
investigations, melatonin has been recognized for successful amelioration of oxidative injury 
and illness due to direct and indirect effects of ionizing radiation and against oxidative 
stress in several experimental and clinical settings. Furthermore, numerous studies have 
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established that melatonin is a highly efficient free radical scavenger, broad antioxidant and 
stimulator of several antioxidants in biological systems. Because of its unique characteristics; 
melatonin has effects not only at the cell level but also within subcellular organelles and 
structures. The antioxidant and prophylatic properties of melatonin allow the use of 
radiation during radiotherapy to get better therapeutic outcomes. Several published articles 
documented that melatonin’s anticancer and oncostatic effects make melatonin an excellent 
candidate and good choice to be used in routine radiotherapies, space travel and following 
nuclear accidents occupational settings where accidental exposure may occur. This article 
will review antioxidant features that put melatonin on top of potentially efficient 
pharmacological radioprotectors. 
2. Ionizing radiation, free radicals & oxidative stress 
Ionizing radiations are types of particle radiation (such as neutron, alpha particles, beta 
particles and cosmic ray) or electromagnetic (such as ultraviolet, X-rays and gamma rays) 
with sufficient energy to ionize atoms or molecules by detaching electrons from their 
valence orbitals. The degree and nature of such ionization depends on the energy of the 
individual particles or on frequency of electromagnetic wave. It is well known that exposure 
to ionizing radiation at sufficiently high doses results in various types of adverse biological 
effects. The biological effect of radiation involves direct and indirect actions. Both actions 
produce molecular changes that mostly need enzymatic repair. Indirect effect involves the 
production of reactive free radicals which produce oxidative mutilation on the key 
molecules. The environmental sources of oxidative attack include, in particularly, specific 
exposures of the organism to ionizing radiations like X-, Ǆ- or cosmic rays and ǂ-particles 
from radon decay as well as UVA and UVB solar light. Ionizing radiations prevalent in 
space, involve a broad range of radiation types and energies from cosmic and unpredictable 
solar sources, representing a very diverse range of ionization qualities and biological 
effectiveness. Linear energy transfer (LET) is a measure of the energy transferred to tissue or 
cells as an ionizing particle travels through it. The LET of the potential radiations can cover 
several orders of magnitude from <1.0 keV µm_1 to > several 100 keV µm_1 (Blakely and 
Chang 2007) Low LET radiation causes damage through reactive oxygen species (ROS) 
production mainly by the radiolysis of water present in living system.  
From a chemical point of view, reactive oxygen species (ROS) and reactive nitrogen species 
(RNS) are oxygen and nitrogen containing molecules constitute the main category of free 
radicals which may be defined as any chemical moiety generated with an unpaired number 
of electrons in valancy orbital. ROS include oxygen-based free radicals, the superoxide anion 
(O2−), hydroxyl (OH), alkoxyl (RO), peroxyl (ROO), and hydroperoxyl (HOO). RNS 
include peroxynitrite (ONOO−), nitric oxide (NO), and nitrogen dioxide (NO2). ROS may 
be radical, such as, O2− and OH, or non-radical, such as, hydrogen peroxide (H2O2) and 
singlet oxygen (1O2). At high concentrations, free radicals can be harmful to living 
organisms. Some ROS damage biomolecules indirectly. For example, H2O2 and O2− initiate 
DNA and lipids damage by interaction with transition metal ion, in particular iron and 
copper, in the metal-catalysed Haber–Weiss reaction, producing OH. It is the most 
electrophilic and reactive of the ROS, with a half-life of~10-9 s (Draganic and Draganic 1971). 
OH can be produced by ultraviolet and ionizing radiations (Von Sonntag 1987). This 
radical is considered the most frequently damaging species. It has been estimated that the 
OH is responsible for 60–70% of the tissue damage caused by ionizing radiations (Galano 
www.intechopen.com
 
Melatonin for Protection Against Ionizing Radiation 
 
445 
et al. 2011). Moreover, OH has great ability to react with almost any molecule in the 
vicinity of where it is generated (Reiter et al. 2010). Chemical nature and reactivity of free 
radicals in biological systems has been recently reviewed (Galano et al. 2011). Once formed 
ROS and RNS can produce a chain reaction. The transfer of the free radical to a biological 
molecule can be sufficiently damaging to cause bond breakage or inactivation of key 
functions. The organic ROO can transfer the radical from molecule to molecule causing 
damage at each encounter. Thus, a cumulative effect can occur, greater than a single 
ionization or broken bond.  
A variety of external events, in particular, exposure to ionizing or ultraviolet radiation, can 
lead to an increase in the generation of ROS in comparison with available antioxidants 
leading to oxidative stress. Oxidative stress is caused by the presence of excessive amount of 
ROS which the cell is unable to counterbalance. This implies that the steady state balance of 
pro-oxidant/anti-oxidant systems in intact cells is shifted to the former. When excessive 
oxidative events occur, the pro-oxidants outbalance the anti-oxidant systems. Moreover, 
oxidative stress may result by overwhelming of antioxidant and DNA repair mechanisms in 
the cell by ROS. In radiation sickness oxidative stress is a factor as either cause or effect. The 
result is oxidation of critical cellular macromolecules including DNA, RNA, proteins and 
lipids eventually leading to cell death in severe oxidative stress. On the other hand, 
moderate oxidative stress may lead to activation of cytoplasmic/nuclear signal transduction 
pathways, modulation of gene and protein expression and alteration of DNA polymerase 
activity, affect the endogenous anti-oxidant systems by down-regulating proteins that 
participate in these systems, and by depleting cellular reserves of anti-oxidants (Acharya et 
al. 2010, Cadet et al. 2010, Little 2000).  
3. Molecular biology effects of ionizing radiation due to free radical 
generation 
As a matter of fact, ionizing radiation penetrating living tissue and can damage all 
important cellular components both through direct ionization and through generating ROS 
due to water radiolysis and induce oxidative damage. Radiation-induced oxidative stress 
was evaluated by three independent approaches; DNA damage, lipid peroxidation and 
protein oxidation. 
3.1 DNA damage 
Cells and their genomic constituent of the living organisms are continually exposed to 
oxidative attacks. Acute exposure to ionizing radiation can create oxidative stress in a cell 
and chronic exposure to this stress can result in permanent changes in the genome (Cooke et 
al. 2003). The main target of ionizing radiation has long since been indicated to be DNA 
which shows wide range of lesions. The oxidatively DNA damage commonly are 
apurinic/apyrimidinic (abasic) DNA sites, oxidized purines and pyrimidines, single strand 
(SSBs) and double strand (DSB) DNA breaks and non-DSB (Kryston et al. 2011). Other initial 
chemical events induced in DNA by ionizing radiation include cross-links, oxidative base 
modification (Hutchinson 1985) and clustered base damage (Goodhead 1994), sugar moiety 
modifications, and deaminated and adducted bases (Cooke et al. 2003, Sedelnikova et al. 
2010, Sutherland et al. 2000, Ward 1994). The numbers of DNA lesions per cell that are 
detected immediately after a radiation dose of 1 Gy have been estimated to be 
approximately greater than 1000 base damage, 1000 SSBs, 40 DSBs, 20 DNA–DNA cross-
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links, 150 DNA–protein cross-links and 160–320 non-DSB clustered DNA damage and 
defective DNA mismatch repair proteins (MMP) (Martin et al. 2010). Recently, it is 
suggested that radiation dose and the type of DNA damage induced may dictate the 
involvement of the MMP system in the cellular response to ionizing radiation. In particular, 
the literature supports a role for the MMP system in DNA damage recognition, cell cycle 
arrest, DNA repair and apoptosis (Martin et al. 2010). In addition, The DNA oxidation 
products are a direct risk to genome stability, and of particular importance are oxidative 
clustered DNA lesions, defined as two or more oxidative lesions present within 10 bp of 
each other (Sedelnikova et al. 2010). 
The most common cellular DNA base modifications are 8-oxo-7,8-dihydroguanine (8-
oxoGua) and 2,6- diamino-4-hydroxy-5-formamidopyrimidine. Both originate from the 
addition of the OH to the C8 position of the guanine ring producing a 8-hydroxy-7,8-
dihydroguanyl radical which can be either oxidized to 8-oxoGua or reduced to give the ring-
opened FapyGua (Altieri et al. 2008, Kryston et al. 2011). The OH interact with pyrimidines 
(thymine and cytosine) at positions 5 or 6 of the ring, and yield several base lesions. The 
most abundant and well known products, 5,6-dihydroxy-5,6-dihydrothymine (thymine 
glycol) and 5,6-dihydroxy-5,6-dihydrocytosine (cytosine glycol). It is generally accepted that 
8-oxodG and thymine glycol are reliable biomarkers of high levels of oxidative stress and 
damage in the human body. These lesions ultimately are not lethal to the cell, but are 
considered to be highly mutagenic. Oxidized bases in DNA are potentially mutagenic and 
so are implicated in the process of carcinogenesis. It has been reported that X-radiation 
induced a significant increase in 8-OHdG concentration in mammary gland DNA (Haegele 
et al. 1998). High levels of 8-OHdG have been observed in normal human epidermis or 
purified DNA exposed to ultraviolet radiation (Wei et al. 1997). Thus, genome stability is 
crucial for maintaining cellular and individual homeostasis, but it is subject to many 
changes due to free radicals attack induced by the exposure to ionizing radiation. DNA 
breaks and fragments resulted from chromosomal damage appear as micronuclei in rapidly 
proliferating cells micronuclei frequency was markedly enhanced in bone marrow cells of 
mouse exposed to 5Gy radiation (Verma et al. 2010). 
Comprehensive reviews have been appeared to give structural and mechanistic information 
on the radiation-induced damage to DNA (Cadet et al. 2010, Cadet et al. 2005). However, 
these authors showed that there is still a dearth of precise data on the formation of 
radiation-induced base injury to DNA in cells and tissues. This is because the determination 
of the radiation-induced base damage within DNA is achieved indirectly by methods 
utilizing hydrolysis of the biopolymer then followed by analysis of the free fragments. The 
situation is even more difficult for cellular DNA since highly sensitive assays are required to 
monitor the formation of very low amounts of injury, typically within the range of one 
modified base per 106 normal nucleotides.  
Direct damage to DNA caused by ionizing radiation has been considered as a significant 
initiator of mutation and cancer. However, some reports suggest that extracellular and 
extranuclear targets may contribute to the genotoxic effects of radiation (Little 2000, Morgan 
2003). In addition, it has been shown that irradiation of the cytoplasm produces gene 
mutations in the nucleus of the hit cells and that this process is mediated by free radicals 
(Wu et al. 1999). Recently, it is proposed that a possible extracellular signal-related kinase 
pathway involving ROS/RNS and COX-2 in the cytoplasmic irradiation-induced 
genotoxicity effect (Hong et al. 2010). Furthermore, it has been demonstrated that nitric 
oxide synthase (NOS) produces sustained high concentrations of nitric oxide (NO) in 
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various mammalian cells after exposure to radiation (Matsumoto et al. 2001). In 
cytoplasmic-irradiated cells, 3-nitrotyrosine, a nitrosated protein product used as a marker 
of ONOO-, was significantly elevated and dramatically inhibited by L-NMMA, (NO 
inhibitor) implicating a critical role of RNS in the mutagenicity induced by cytoplasmic 
irradiation (Hong et al. 2010). 
3.2 Lipid peroxidation 
The direct and indirect destructive effects of ionizing radiation lead to peroxidation of 
macromolecules, especially those present in lipid-rich membrane structures, lipoproteins 
and chromatin lipids. Phospholipids in membranes and triglycerides in LDL are highly 
susceptible to free radical attacks. Once the process of lipid peroxidation is started, it 
proceeds as a free radical-mediated chain reaction involving initiation, propagation, and 
termination (Gago-Dominguez et al. 2005). The first step (initiation) in the lipid peroxidation 
process is the abstraction of a hydrogen atom, from a methylene group next to a double 
bond in polyunsaturated fatty acids. This produces a carbon centered radical which undergo 
rearrangement of the double bond to form a stable conjugated diene. In propagation step, 
carbon centered radicals react with oxygen to form new ROO that react further with 
another neighboring lipid molecule forming a hydroperoxy group and a new carbon 
centered radicals. The lipid hydroperoxide will react further to form cyclic peroxide, cyclic 
endoperoxide, and finally aldehydes. The propagation phase can repeat many times until it 
is terminated by chain breaking antioxidants (Halliwell 2009, Reed 2011). 
During lipid peroxidative pathway, several end products are formed such as 
malondialdehyde (MDA) and 4-hydroxy-2-nonenal (4-HNE), pentane and ethane, 2,3 
transconjugated dienes, isoprostanes and cholesteroloxides (Catala 2009, Tuma 2002). These 
aldehydes are highly reactive and bind with DNA and proteins and form adducts which 
inhibit proteins functions and can disrupt nuclear events. The aldehydes are more diffusible 
than free radicals, thus injury can occur in distant locations. The aldehyde can be found in 
measurable concentrations in biological fluids and analytical methods used are sometimes 
complex and require sample preparation involving extraction and purification steps. 
Isoprostanes, prostaglandin like compounds, are generated from the free radical-initiated 
peroxidation of arachidonic acid. F2-isoprostanes are the most specific markers of lipid 
peroxidation and the most difficult to measure (Comporti et al. 2008). The mostly frequently 
lipid peroxidation markers used in free radical research are MDA and 4-HNE. Lipid 
peroxidation was assessed as thiobarbituric acid reactive substances (TBARS) in biological 
materials using thiobarbituric acid reaction method (Esterbauer and Zollner 1989, Moller 
and Loft 2010).  
Several studies have examined the radiation-induced free radical damage evidenced by the 
elevation of lipid peroxidation levels. Lipid peroxidation-derived products have been 
implicated in the pathogenesis of oxidative stress-associated radiation sickness and diseases. 
Aldehydes showed significant increase with increasing doses of ionizing radiation in several 
organs (Bhatia and Manda 2004, Sener et al. 2003) and mitochondrial membranes (Kamat et 
al. 2000). A significant increase in DNA strand breaks and TBARS concentrations was found 
in rat brain exposed to 10Gy ionizing radiation (Undeger et al. 2004). Exposure to 5 Gy 
irradiation led to considerable elevation of MDA level in thymus, brain, jejunum liver and 
kidney of total body irradiated mice (Taysi et al. 2003, Verma et al. 2010) after 24 hrs of 
irradiation continued up to 48 hrs. Lipid peroxidation due to OH attack were found to be 
in a radiation dose-dependent manner but no significant differences between radiation 
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resistant and radiation sensitive rats were detectable after whole-body-irradiation with x-
rays at 2, 4, and 6 Gy. Among the subcellular organelles mitochondria are one of the key 
components of the cell injured by radiation-induced oxidative stress. In an interesting study, 
mitochondria from rat brain and liver was isolated then exposed to 450Gy gamma radiation. 
In this study there was considerable increase in lipid hydroperoxide (LOOH) and MDA in 
rat liver and brain mitochondria (Lakshmi et al. 2005). Recent research showed that 
increased free radicals due to radiation exposure damage membrane lipids, which results in 
cell lysis due to altered membrane fluidity (Gulbahar et al. 2009).  
The ideas about the leading role of lipid peroxidation in radiation damage of cells and 
tissues arose from the damaging of cell membrane structures. Peroxidation of lipids can 
greatly alter the physicochemical properties of membrane lipid bilayers, resulting in severe 
cellular dysfunction. It causes the change in structure, fluidity and permeability of 
membranes and inactivates several membrane associated enzymes and protein receptors. In 
biological membranes, lipid peroxidation is also usually accompanied by oxidation of 
membrane proteins. In consequence, peroxidation of lipids may change the agreement of 
proteins in bilayers and by that interfere with their physiological role on the membrane 
function.  
3.3 Protein oxidation  
As defined earlier, ionizing radiation can interact and modify all cellular components both 
through direct ionization and through induction of ROS resulting in a variety of subtle and 
profound biological effects. Radiation-induced oxidative protein damage can be started by 
even quite low doses of radiation and can produce an alteration of the cellular redox 
balance, which lasts for substantial time after exposure and may contribute to changes in cell 
survival, proliferation, and differentiation(Shuryak and Brenner 2009). Several damages to 
the peptide chain or to the side-chains of amino acid residues have been identified, and 
some of their mechanisms of formation has been described (Griffiths et al. 2002).  
Available data from various studies raveled that the most sensitive amino acids, cysteine, 
tryptophan, tyrosine and methionine, bear aromatic or sulphur-containing side-chains. 
Furthermore, protein oxidation can lead to hydroxylation of aromatic groups and aliphatic 
amino acid side chains, nitration of aromatic amino acid residues, nitrosylation of sulfhydryl 
groups, sulfoxidation of methionine residues, chlorination of aromatic groups and primary 
amino groups, and to conversion of some amino acid residues to carbonyl derivatives 
(Catala 2007). The fundamental mechanisms involved in the oxidation of proteins by ROS 
were described by studies in which amino acids, peptides, and proteins were exposed to 
ionizing radiations under conditions where OH or a mixture of OH and O2− are formed 
(Stadtman 2004). It has been demonstrated that the attack by OH leads to an abstraction of 
a hydrogen atom from the protein polypeptide backbone and form a carbon-centered 
radical (Klaunig et al. 2011, Stadtman 2004). Oxidation due to radiation exposure can lead 
also to cleavage of the polypeptide chain and formation of cross-linked protein aggregates. 
Because the generation of carbonyl derivatives occurs by many different mechanisms, the 
level of carbonyl groups in proteins is widely used as a marker of oxidative protein damage 
(Guajardo et al. 2006). Studies performed with various tissues have revealed that radiation 
increases protein oxidation and carbonyl levels as well as produces structural and functional 
changes (Gulbahar et al. 2009).  
In most reports describing the in vivo experiments on radiation sickness, the carbonyl levels 
were determined in tissue homogenates or soluble cytoplasmic proteins. Moreover, it is very 
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important to consider the carbonyl levels in different subcellular fractions, since they may 
show different susceptibility to oxidative damage, probably due to differences in their 
protein composition or activities of their antioxidant defenses, and, therefore, make different 
contribution to the impairment of cell functioning with radiation responses. 
Numerous investigations showed that protein carbonyls, a marker of primary protein 
damage indicated a higher magnitude of damage in irradiated mice brains exposed to 1.5 
Gy high-LET 56Fe beams (500 MeV/nucleon, 1.5 Gy). This effect was associated with 
impaired cognitive behavior of mice at day 30 post-exposure as well as apoptotic and 
necrotic cell death of granule cells and Purkinje cells (Manda et al. 2008). Ǆ-irradiation of rats 
at a dose of 10 Gy caused increases in protein carbonyl groups in mitochondria and 
cytoplasm both in liver and spleen. Similar results have been obtained for homogenates of 
different tissues isolated from Ǆ-irradiated gerbils and rats (Sohal et al. 1995). Post-
irradiation accumulation of oxidized proteins in subcellular fractions, especially if occurring 
in nuclei, might probably affect not only the catalytic properties of enzymes but also the 
regulation of radiation-induced gene expression by interfering with the activation of 
transcription factors (Whisler et al. 1997). Among the nuclear proteins, histones are likely 
most susceptible to oxidative modification, due to high contents of lysine and arginine 
residues in their molecules. Information on the formation of radicals on peptides and 
proteins and how radical damage may be propagated and transferred within protein 
structures have been reviewed (Hawkins and Davies 2001). 
4. Defenses against free radicals 
Human and all of the aerobic organisms have a very efficient defense network of 
antioxidants against oxidative stress. An antioxidant can be defined as a molecule or an 
element that, when present at low concentrations compared to those of the oxidizable 
substrate, significantly combat, delays and inhibit oxidation of that substrate, thus, prevent 
free radicals from damaging healthy cells (Halliwell 1997, 2009). Under normal condition, 
cells have well coordinated and efficient endogenous antioxidant defense systems, which 
protect against the injurious effects of oxidants. 
From the viewpoint of mechanistic functions, antioxidant defense mechanisms can be 
classified into the following five lines of defenses: preventing antioxidants, scavenging 
antioxidants, repair and de novo antioxidants, adaptive antioxidants, and finally cellular 
signaling messenger (Halliwell 1997, Niki 2010). The first line of defense is the preventing 
antioxidants which act by suppressing the formation of ROS and RNS by reducing H2O2 and 
lipid hydroperoxides that are generated during lipid peroxidation, to water and lipid 
hydroxides, respectively, or sequestering pro-oxidant metal ions such as iron and copper by 
some binding of proteins (e.g., transferrin, metallothionein). The second line of defense can 
be described as the scavenging antioxidants which exist to intercept, or scavenge free 
radicals and remove active species rapidly before attacking biologically essential molecules. 
For example; superoxide dismutase (SOD) converts O2− to H2O2, while ǂ-tocopherol and 
carotenoids are efficient scavenger of 1O2 (Inoue et al. 2011). Many phenolic compounds and 
aromatic amines act as a free radical-scavenging antioxidant. There is a general agreement 
that electron transfer and hydrogen transfer are the main mechanisms involved in the 
reactions of melatonin with free radicals. The third line of defenses is various enzymes 
which function by repairing damages, clearing the wastes, and reconstituting the lost 
function. The adaptation mechanism is considered the fourth line of defense, in which 
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appropriate antioxidants are released at the right time and transported to the right site in 
right concentration. Some antioxidants constitute the fifth line of defense by functioning as a 
cellular signaling messenger to control the level of antioxidant compounds and enzymes 
(Niki and Noguchi 2000, Noguchi and Niki 2000). 
5. Radioprotectors and mitigators of radiation induced injury 
Generally, any chemical/biological agents given before to or at the time of irradiation to 
prevent or ameliorate damage to normal tissues are termed radioprotectors. While 
mitigators of normal tissue injury are agents delivered at the end of irradiation, or after 
irradiation is complete, but prior to the manifestation of normal tissue toxicity. The 
estimated time scale to use mitigators efficiently ranges from seconds to hours after 
radiation exposure. Agents delivered to improve established normal tissue toxicity are 
considered treatments which can be monitored over weeks to years after radiation exposure 
(Citrin et al. 2010). Since radiotherapy, occupational, accidental exposure to radiation or 
space travel and exploration can produce unwanted side effects, it is important to prevent 
such effects by the use of radioprotectors or mitigators. Ideally, radioprotective and 
mitigative agent should fulfill several characteristics that relate to the ability of the agent to 
improve the therapeutic results. First, the agent should have protective effects on the 
majority of organs and tissues. Second, the agent must reach all cells and organelles and can 
easily penetrate cellular membranes. Third, it must have an acceptable route of 
administration (preferably oral or alternatively intramuscular) and with minimal toxicity. 
Fourth, to be useful in the radiotherapy settings, radioprotectant should be selective in 
protecting normal tissues from radiotherapy without protecting tumor tissue. Finally, to a 
large extent radioprotectors should be compatible with the wide range of other drugs that 
will be prescribe to patients. Moreover, because free radicals are responsible for injury 
caused by ionizing radiation, therefore, for an agent to protect cells from primary free 
radical damage, the agent needs to be present at the time of radiation and in sufficient 
concentration to compete with radicals produced through radical-scavenging mechanisms 
(Citrin et al. 2010, Hosseinimehr 2007, Shirazi et al. 2007). 
A large body of literature describes radioprotection or mitigation with a variety of agents 
after total body or localized exposures. A complete and comprehensive review of these 
agents is outside the scope of this chapter. Herein, we briefly highlight melatonin that have 
been described as radiation protectors and mitigators, and attempt to focus on it with 
demonstrated or anticipated usefulness for therapeutic radiation exposures. As defined 
above, an ideal radioprotectors need to have radical-scavenging properties and can also 
exert broad antioxidant activity. Whereas all antioxidants cannot afford full radioprotection, 
melatonin verify most of the criteria needed for efficient radioprotector , mitigators and 
treatment agent with antioxidant potential, radical scavenging characteristics and stimulator 
of intrinsic antioxidants. 
6. Melatonin  
6.1 Synthesis, distribution, and metabolism 
Melatonin synthesis in the pineal gland has been reviewed in significant detail (Reiter 2003). 
In summary, pinealocytes take up L-tryprophane from blood. Via several enzymatic steps 
including tryptophan 5-hydroxylation, decarboxylation, N-acetylation and O-methylation, 
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in that sequence, N-acetyl-5-methoxytryptamine (melatonin) is synthesized. It is secreted 
upon biosynthesis into the extracellular fluid to the general circulation from which it easily 
crosses various cellular membranes. It is secreted by the pineal gland and its levels have 
diurnal variation and also fluctuate with sleep stages. They are higher during night 
(Luboshitzky et al. 1999). The diurnal/nocturnal levels of blood melatonin can range 
between 8 ± 2 pg/mL (light phase) and 81 ± 11 pg/mL (dark phase). The synthesis and 
presence of melatonin have also been demonstrated in non-pineal tissues such as retina, 
Harderian gland, gastrointestinal track, testes, and human lymphocytes. Furthermore, the 
distribution of melatonin in the human being is very broad (Reiter 2003). Once synthesized, 
the majority of melatonin diffuses directly towards the cerebrospinal fluid of the brain's 
third ventricle, while another fraction is released into the blood stream where it is 
distributed to all tissues and body fluids (Cheung et al. 2006). It is found in serum, saliva 
(Cutando et al. 2011, Novakova et al. 2011), cerebrospinal fluids (Rousseau et al. 1999), and 
aqueous humor of the eye (Chiquet et al. 2006), ovarian follicular fluid, hepato-
gastrointestinal tissues (Messner et al. 2001). Melatonin in the milk of lactating mothers 
exhibits a marked daily rhythm, with high levels during the night and undetectable levels 
during the day (Illnerova et al. 1993, Sanchez-Barcelo et al. 2011). Moreover, melatonin 
production is not confined exclusively to the pineal gland, but other tissues including retina, 
Harderian glands, gut, ovary, testes, bone marrow and lens also produce it (Esposito and 
Cuzzocrea 2010). 
Melatonin has two important functional groups which determine its specificity and 
amphiphilicity; the 5-methoxy group and the N-acetyl side chain. In liver melatonin is 
metabolized by P- 450 hepatic enzymes, which hydroxylate this hormone at the 6- carbon 
position to yield 6- hydroxymelatonin which conjugated with sulfuric or glucuronic acid, to 
produce the principal urinary metabolite, 6-sulfatoxymelatonin. In the final stage, 
conjugated melatonin and minute quantities of unmetabolized melatonin are excreted 
through the kidney. In addition to hepatic metabolism, oxidative pyrrole-ring cleavage 
appears to be the major metabolic pathway in other tissues, including the central nervous 
system (Esposito and Cuzzocrea 2010). 
A plethora of evidence suggests that melatonin mediates a variety of physiological 
responses through membrane and nuclear binding sites. In mammals, the mechanisms of 
action of melatonin include the involvement of high affinity G protein-coupled membrane 
receptors (MT1, MT2), cytosolic binding sites (MT3 and calmodulin), and nuclear receptors 
of the RZR/ROR family. Melatonin also has receptor-independent activity and can directly 
scavenge free radicals. A disulfide bond between Cys 113 and Cys 190 is essential for high-
affinity melatonin binding to MT2 and possibly to MT1 receptors (Dubocovich and 
Markowska 2005). RZR/ROR family is expressed in a variety of organs. It presumably 
regulates the immune system and circadian cycles via the nuclear receptor and these also 
may be involved in its regulation of antioxidative enzymes (Cutando et al. 2011). 
6.2 Melatonin and factors that determine antioxidant capacity 
A number of criteria that characterize an ideal free radical scavenging antioxidant can be 
identified. First, because free radicals are highly reactive with very short half life time, 
therefore, an efficient antioxidant should be ubiquitous and present in adequate amounts in 
tissues and cells. Furthermore, the biological systems are heterogeneous in nature, which 
affects the action and efficacy of antioxidants. Both hydrophilic and lipophilic antioxidants 
act at respective site. Some antioxidants are present in free form, but others as metabolite or 
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in bound form (Niki 2010). In contrast to other antioxidants that are either hydrophilic or 
lipophilic, melatonin is an amphiphilic small size molecule (Giacomo and Antonio 2007). 
These features of melatonin allow it to cross all morphophysiological barriers and to interact 
with toxic molecules throughout the cell and its organelles, thereby reducing oxidative 
damage to molecules in both the lipid and aqueous environments of cells. Numerous 
articles documented that melatonin is widely distributed and found in all body fluids, 
organs, cells and organelles. Recently, melatonin levels in the cell membrane, cytosol, 
nucleus, and mitochondrion was found to vary over a 24-hr cycle, although these variations 
do not exhibit circadian rhythms. The cell membrane has the highest concentration of 
melatonin followed by mitochondria, nucleus, and cytosol (Venegas et al. 2011). 
Second, an efficient antioxidant should react with most of free radicals because as it is well 
known that free radicals are variable in their biological, chemical and physical properties 
that involved in the oxidative stress. In functional terms, have reported that melatonin 
exerts a host of antioxidant effects that can be described as a broad spectrum antioxidant 
(Karbownik and Reiter 2000). Initially, (Hardeland et al. 1993a, Hardeland et al. 1993b, Tan 
et al. 1993) are the first who documented that melatonin is a remarkably potent scavenger of 
the particularly reactive, destructive, mutagenic and carcinogenic OH. It is documented 
that, melatonin is a more efficient OH scavenger than either glutathione or mannitol, and 
that melatonin reacts at a diffusion-controlled rate with the OH. Thus, melatonin is 
probably an important endogenously produced antioxidant. Extensive studies have 
established that melatonin is much more specific than its structural analogs in undergoing 
reactions which lead to the termination of the radical reaction chain and in avoiding 
prooxidant, carbon or oxygen centered intermediates (Hardeland et al. 2011, Poeggeler et al. 
2002, Tan et al. 1993). Besides the OH, melatonin in cell-free systems has been shown to 
directly scavenge H2O2, 1O2 and HOCl with little ability to scavenge the O2–. Furthermore, 
melatonin scavenges nitric oxide (NO) and suppresses the activity of its rate limiting 
enzyme, nitric oxide synthase (NOS), thereby inhibiting the formation of the ONOO-. In 
addition, melatonin scavenges a number of RNS including ONOO- and peroxynitrous acid 
(ONOOH). Moreover, melatonin has proven to scavenge alkoxyl, peroxyl radicals. The 
peroxyl radical (POO), which is formed during the complex process of lipid peroxidation, 
is highly destructive to cells, because, once formed, it can propagate the process of lipid 
peroxidation. Therefore, agents that neutralize the POO radical are generally known as 
chain breaking antioxidants, is important to maintaining the optimal function of not only 
cell membranes, but of cells themselves. It is estimated that each molecule of melatonin 
scavenged four POO molecules (Pieri et al. 1994, Pieri et al. 1995), which would  
make it twice as effective as vitamin E, the principal well known chain-breaking  
lipid antioxidant and POO scavenger. The most important products of melatonin’s 
interaction with H2O2, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), N-acetyl-5-
methoxykynuramine(AMK), and 6-hydroxymelatonin, are also a highly efficient radical 
scavenger (Maharaj et al. 2003). The cascade of reactions where the secondary metabolites 
are also effective scavenges is believed to contribute to melatonin’s high efficacy in reducing 
oxidative damage. 
Very relevant to the development of this chapter is an alternate concept proposed to explain 
the protective effects of melatonin at the level of radical generation rather than 
detoxification of radicals already formed. It has been suggested that if melatonin is capable 
of decreasing the processes leading to enhanced radical formation, this might be achieved 
by low concentrations of the indole (Hardeland et al. 2011). Therefore, the main sources of 
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free radicals should be investigated with regard to their modulation by melatonin and their 
sensitivity to the stressor. In addition to free radicals generated by leukocytes, mitochondria 
should be mentioned as main sources. In support of this suggestion, melatonin may also 
reduce free radical generation in mitochondria by improving oxidative phosphorylation, 
thereby lowering electron leakage and increasing ATP generation (Acuna-Castroviejo et al. 
2001). 
In addition to its direct free radical scavenging actions, melatonin influences both functional 
integrity of other antioxidative enzymes and cellular mRNA levels for these enzymes. Many 
studies documented the influence of melatonin on the activity and expression of the 
antioxidants both under physiological and under conditions of elevated oxidative stress. As 
an indirect antioxidant, melatonin stimulates gene expression and activity of SOD, thereby 
inducing the rapid conversion of O2– to H2O2. The removal of O2– by SOD also leads to a 
reduced formation of the highly reactive and damaging ONOO-. Catalase (CAT) and 
glutathione peroxidase (GSH-Px), enzymes that metabolizes H2O2 to H2O, have also been 
shown to be stimulated by melatonin (Karbownik and Reiter 2000). In fact, it was 
demonstrated by several investigator that melatonin stimulates the rate-limiting enzyme, Ǆ-
glutamylcysteine synthase thereby increasing the level of an important endogenous 
antioxidant, glutathione (GSH) (El-Missiry et al. 2007, Othman et al. 2008, Urata et al. 1999) 
which, besides being a radical scavenger, is used by GSH-Px as a substrate to metabolize 
H2O2. In this process, GSH is converted to oxidized glutathione (GSSG). To maintain high 
levels of GSH, melatonin promotes the activity of glutathione reductase, which converts 
GSSG back to GSH. The possible intracellular mechanisms and pathways by which 
melatonin regulates antioxidant enzymes were reviewed (Rodriguez et al. 2004). 
An added value of melatonin is that its metabolite N1-acetyl-N2-formyl-5-
methoxykynuramine (AFMK) also has remarkable antioxidant properties and redox 
potential (Tan et al. 2001). It is formed when melatonin interacts with ROS, in particular, 1O2 
and H2O2. AFMK can be then enzymatically converted, by CAT, to N1-acetyl-5- 
methoxykynuramine (AMK). Cyclic 3-hydroxymelatonin (C3-OHM) is another product 
formed from melatonin by its interactions with free radicals, (Tan et al. 1998), which can be 
further metabolized by free radicals to AFMK (Tan et al. 2003). All these findings indicate 
that AFMK is a central metabolite of melatonin oxidation especially in nonhepatic tissues.  
Interestingly, melatonin was shown to prevent the loss of important dietary antioxidants 
including Vitamins C and E (Susa et al. 1997), bind iron and participate in maintaining iron 
pool at appropriate level resulting in control of iron haemostasis, thereby providing tissue 
protection (Othman et al. 2008). Furthermore, melatonin enhances antioxidant action of a-
tocopherol and ascorbate against NADPH- and iron-dependent lipid peroxidation in human 
placental mitochondria (Milczarek et al. 2010). 
The bioavailability is the main factor that determines the capacity of antioxidants in vivo. 
The antioxidants should be absorbed, transported, distributed, and retained properly in the 
biological fluids, cells and tissues (Cheeseman and Slater 1993, Niki 2010). Recently, it has 
been suggested that melatonin present in edible plants may improve human health, by 
virtue of its biological activities and its good bioavailability (Iriti et al. 2010). This could add 
a new factor to the of health benefits for patients associated to radiotherapy. Melatonin’s 
interactions with other drugs that influence its bioavailability were summarized (Tan et al. 
2007). Furthermore, melatonin can be administered by virtually any route, including orally, 
via submucosal or transdermal patches, sublingually, intranasally, intravenously (Reiter 
2003). 
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6.3 Radioprotective effect of melatonin and its metabolites 
The radiosensitivity of cells to ionizing radiation depends on several factors including the 
efficiency of the endogenous antioxidative defense systems to prevent oxidative stress. A 
number of natural and synthetic compounds have been investigated for their antioxidative 
as well as radioprotective potential. Most of the effective compounds were found to have 
some inconvenient side effects such as hypotention, hypocalcemia, nausea, vomiting and 
hot flashes. Furthermore, most of compounds must be given intravenously or 
subcutaneously which restrict their clinical application outside of controlled clinical 
situations. Thus, a need still exists for identifying a non-toxic, effective, and convenient 
compound to protect humans against radiation damage in accidental, occupational, clinical 
settings and space-travel. Melatonin received much attention for its unique antioxidative 
potential at a very low concentration compared with other antioxidants.  
A number of in vitro and in vivo studies have reported that exogenously administered 
melatonin provides profound protection against radiation induced lipid peroxidation and 
oxidative stress (El-Missiry et al. 2007, Taysi et al. 2003). As indicated above, radiation-
induced lipid peroxidation is a three steps free radical process. Melatonin inhibits lipid 
peroxidation by preventing the initiation phase of lipid peroxidation and interrupting the 
chain reaction. This is mainly due to melatonin ability to quench OH and several other 
ROS and RNS. It has been reported to scavenge the several ROS, in particular OH and the 
ONOO-. When melatonin interacts with OH it becomes indolyl (melatonyl) radical which 
has very low toxicity. After some molecular rearrangements, the melatonyl radical 
scavenges a second OH to form cyclic 3-hydroxymelatonin (3-OHM). Thus, this reaction 
pathway suggests that 3-OHM is the footprint product of the interaction between melatonin 
with OH. 3-OHM was also detected in the urine of both rats and humans. This provides 
direct evidence that melatonin, under physiological conditions, functions as an antioxidant 
to detoxify the most reactive and cytotoxic endogenous OH (Tan et al., 1999). When rats 
were exposed to ionizing radiation which results in OH generation, urinary 3-OHM 
increased significantly compared to that of controls (Tan et al. 1998). This provided direct 
evidence that radiation induced oxidative stress increases melatonin consumption in rats. 
The rapid decrease in circulating melatonin under conditions of excessive stress can be 
considered a protective mechanism for organisms against highly damaging free radicals; in 
this sense, melatonin can be categorized as a first line of defensive molecule (Tan et al. 2007).  
Along this line, the melatonin’s metabolite AFMK protected against space radiation induced 
impairment of memory and hippocampal neurogenesis in adult C57BL mice (Manda et al. 
2008). This study demonstrated that radiation exposure (2.0 Gy of 500 MeV/nucleon 56Fe 
beams, a ground-based model of space radiation) significantly reduced the spatial memory 
of mice without affecting their motor activity. It is also reported that AFMK pretreatment 
significantly ameliorated radiation induced neurobehavioral ailments and reduced the loss 
of doublecortin and cell proliferation. Radiation exposure dramatically augmented the level 
of 8-OHdG in serum as well as DNA migration in the comet tail were impaired by AFMK 
pretreatment. In addition, radiation-induced augmentation of protein carbonyl content and 
4-HNE + MDA and reduced the level of brain sulfhydryl contents was ameliorated by 
AFMK pretreatment (Manda et al. 2008). The ameliorating action of AFMK against radiation 
induced lipid peroxidation was attributed to free-radical scavenging property of AFMK. In 
vitro, AFMK showed a very high level of OH scavenging potential which was measured 
by an electron spin resonance spin study of the 2-hydroxy-5,5-dimethyl-1-pyrrolineN-oxide 
(DMPO-OH) adduct. In this experiment, 10 Gy of X-ray for the radiolysis of water with 
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different concentration of AFMK was used and intensity of spin adduct (DMPO-OH) were 
measured by ESR (Manda et al. 2007). 
Extensive studies have established that pretreatment with melatonin at physiological dose 5 
mg/kg or pharmacological dose 10 mg/kg bw significantly decreased MDA and NO 
levels. The data documented that melatonin reduces tissue damage inflicted by irradiation 
when given prior to the exposure to ionizing radiation (Babicova et al. 2011, Taysi et al. 
2003, Verma et al. 2010). These authors explained that NO is formed in higher amounts 
from L-arginine by inducible nitric oxide synthase (iNOS) during early response to ionizing 
radiation presumably as a part of signal transduction pathways (Babicova et al. 2011). Its 
cytotoxicity is primarily due to the production of ONOO-, a toxic oxidant, generated when 
the NO couples with O2- (El-Sokkary et al. 2002). The processes triggered by ONOO- 
include initiation of lipid peroxidation, inhibition of mitochondrial respiration, inhibition of 
membrane pumps, depletion of GSH, and damage to DNA. Melatonin is reported to 
scavenge ONOO- both in vitro and in vivo (El-Sokkary et al. 1999, Gilad et al. 1997) and to 
inhibit iNOS activity thereby reducing excessive NO generation.  
It should emphasized that ionizing radiation causes oxidative damage to tissues within an 
extremely short period, and possible protection against it would require the rapid transfer of 
antioxidants to the sensitive sites in cells. At this point, melatonin seems unique among 
cellular antioxidants because of its physical and chemical properties; it can easily cross 
biological membranes and reach the cytosol, nucleus, and cellular compartments 
(Menendez-Pelaez and Reiter 1993). The effect of melatonin in maintaining normal hepatic 
and renal functions may be related to its ability to localize mainly in a superficial position in 
the lipid bilayer near the polar heads of membrane phospholipids (El-Sokkary et al. 2002). 
The protective action of melatonin against lipid and protein oxidation as a factor modifying 
membrane organization may also be related to melatonin’s ability to scavenge the oxidation-
initiating agents, which are produced during the oxidation of proteins and lipids. Since 
membrane functions and structure are influenced by proteins in membranes and radiation is 
known to damage thiol proteins (Biaglow et al. 2003), it is possible that the protective action 
of melatonin against membrane damage may be related partially to the ability of melatonin 
to prevent lipid and protein oxidative damage (Le Maire et al. 1990). Changes in membrane 
structure and fluidity due to ROS reactivity after irradiation are also attributed to graded 
alterations in the lipid bilayer environment (Karbownik and Reiter 2000). It has been 
suggested that the protective role of melatonin in preserving optimal levels of fluidity of the 
biological membranes may be related to its ability to reduce lipid peroxidation (Garcia et al. 
1997, Garcia et al. 2001). 
Moreover, melatonin prevents inflammation and MDA caused by abdominopelvic and total 
body irradiation of rat (Taysi et al. 2003). Thus, the radioprotective effect of melatonin is 
likely achieved by its ability to function as a scavenger for free radicals generated by 
ionizing radiation. Furthermore, these findings may suggest that melatonin may enable the 
use of higher doses of radiation during therapy and may therefore allow higher dose rates 
in some patients with cancer. In another study, pretreatment with melatonin (10mg/kg bw) 
for 4 days before acute Ǆ-irradiation significantly abolished radiation induced elevations in 
MDA and protein carbonyl levels in the liver and significantly prevented the decrease in 
hepatic GSH content, GST, and CAT activities. Moreover, preirradiation treatment with 
melatonin showed significantly higher hepatic DNA and RNA contents than irradiated rats. 
The levels of total lipids, cholesterol, triglycerides (TG), high density lipoproteins (HDL), 
low density lipoproteins (LDL), total proteins, albumin, total globulins, creatinine, and urea, 
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as well as the activities of AST, ALT, and GGT in serum were significantly ameliorated 
when melatonin was injected before irradiation. The protection evidenced by normalization 
of the clinical parameters was associated with and attributed to decreased lipid peroxidation 
in the presence of melatonin. This data indicate that melatonin has a radioprotective impact 
against ionizing-radiation induced oxidative stress and organ injury (El-Missiry et al. 2007). 
At sufficiently high radiation doses, GSH becomes depleted, leaving highly reactive ROS, 
beyond the immediate and normal needs of the cell, to react with critical cellular 
biomolecules and cause tissue damage. The concentration of intracellular GSH, therefore, is 
the key determinant of the extent of radiation-induced tissue injury. Thus, interest has been 
focused on melatonin, which acts as an antioxidant and is capable of stimulating GSH 
synthesis. It has been shown that melatonin enhances intracellular GSH levels by 
stimulating the rate-limiting enzyme in its synthesis, Ǆ-glutamylcysteine synthase, which 
inhibits the peroxidative enzymes NOS and lipoxygenase. Experimentally, melatonin is 
demonstrated to increase hepatic GSH content, (El-Missiry et al. 2007, Sener et al. 2003), and 
hence to inhibit formation of extracellular and intracellular ROS (Reiter et al. 2004). It is also 
proposed that prevention of GSH depletion is the most efficient method of direct protection 
against radiation-induced oxidative toxicity. A significant decrease in hepatic GST activity 
and increase in serum GGT activity was recorded after exposure to 2&4 Gy (El-Missiry et al. 
2007, Sridharan and Shyamaladevi 2002), and 10 Gy gamma irradiation (Samanta et al. 
2004). Melatonin treatment at a dose level of 10mg/Kg bw before irradiation significantly 
countered radiation-induced decrease in the activities of these enzymes in the liver and 
serum. Furthermore, melatonin increases the activity of GSH-Px (Barlow-Walden et al. 1995) 
and superoxide dismutase (Antolin et al. 1996). These findings support the conclusion that 
melatonin affords radioprotection by modulating antioxidative enzyme activities in the 
body (El-Missiry et al. 2007). 
Al the level of clinical markers, like cholesterol, TG, LDL, and free radicals are also risk 
factors that tend to damage arteries, leading to cardiovascular diseases. Pre-irradiation 
treatment with melatonin is found to reduce serum cholesterol, TG, and LDL levels in 
serum, indicating modulation of lipid metabolism in cells. It is well reported that 
antioxidants reduce oxidation susceptibility of HDL (Schnell et al. 2001) and control 
hyperlipidaemia (Mary et al. 2002). This might potentiate antiatherogenic effects of 
antioxidants including melatonin. Therefore, it is suggested that preirradiation treatment 
with melatonin appears to be hypolipidemic which might potentate its beneficial use in 
occupational, clinical, and space settings (El-Missiry et al. 2007). 
Ionizing irradiation is among reproductive harmful agent and is widely identified to affect 
testicular function, morphology and spermatogenesis. Irradiation of the testes can produce 
reversible or permanent sterility in males. In an experiment, rats were subjected to sublethal 
irradiation dose of 8 Gy, either to the total body or abdominopelvic region using a 60Co 
source. In this experiment, melatonin pretreatment resulted in less apoptosis as indicated by 
a considerable decrease in caspace-3 immunoreactivity. Electron microscopic examination 
showed that all spermatogenic cells, especially primary spermatocytes, displayed 
considerably inhibited of degeneration in the groups treated with melatonin before total 
body and abdominopelvic irradiation (Take et al. 2009). 
An extensive literature implicates cellular DNA as the primary target for the biological and 
lethal effects of ionizing radiation. Melatonin has the ability to protect the DNA of 
hematopoietic cells of mice from the damaging effects of acute whole-body irradiation 
(Vijayalaxmi et al. 1999). The radioprotective ability of melatonin was investigated in the 
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Indian tropical rodent, Funambulus pennanti during its reproductively inactive phase when 
peripheral melatonin is high and the animal is under the influence of environmental 
stresses. Exogenous melatonin with its anti-apoptotic and antioxidant properties additively 
increased the immunity of the squirrels, by protecting their hematopoietic system and 
lymphoid organs against X-ray radiation induced cellular toxicity (Sharma et al. 2008). 
Human keratinocytes is the main target cells in epidermal photodamage. Protection against 
UVR-induced skin damage was manifested by suppression of UV-induced erythema by 
topical pretreatment with melatonin with ⁄ without combination of vitamins C and E 
(Bangha et al. 1997, Dreher et al. 1998). Melatonin increased cell survival of HaCaT 
keratinocytes and ensured keratinocyte colony growth under UV-induced stress and 
showed decrease of UV-induced DNA fragmentation. Also, transcription of several classical 
target genes which are up-regulated after UV-exposure and play an important role in the 
execution of skin photodamage were down-regulated in HaCaT keratinocytes by melatonin 
pretreatment. It has been previously reported that melatonin reduces UVB-induced cell 
damage and polyamine levels in human skin fibroblasts (Lee et al. 2003). Furthermore, it 
was reported that melatonin increases survival of HaCaT keratinocytes by suppressing UV-
induced apoptosis (Fischer et al. 2006). The molecular mechanisms underlying protective 
effects of melatonin on human keratinocytes and human fibroblasts upon UVB induced-
apoptotic cell death was investigated (Cho et al. 2007). In this study, cDNA microarray 
analysis was perform from HaCaT keratinocytes, exposed to 100 mJ ⁄cm2 and pretreated 
with melatonin for 30 min. Data showed that melatonin inhibits the expression of apoptosis 
related protein-3, apoptotic chromatin condensation inducer in the nucleus, and glutathione 
peroxidase 1 in UVB-irradiated HaCaT cells. The inhibitory effect of melatonin upon UVB 
irradiation is likely to be associated with antioxidant capacity of melatonin, thereby 
suggesting that melatonin may be used as a sunscreen agent to reduce cell death of 
keratinocytes after excessive UVB irradiation. 
Radiotherapy plays an important role as part of the multimodality treatment for a number 
of malignancies in children. In young children, significant growth arrest was demonstrated 
with fractionated doses of 15 Gy and above as well as, in children less than one year of age, 
with doses as low as 10 Gy (Robertson et al. 1991). Proliferating chondrocytes, distal 
metaphyseal vessels, and epiphyseal vasculature are main targets for radiation-induced 
injury of bone growth plate (Kember 1967). Proliferating chondrocytes show marked 
cytological changes and cell death with a single fraction of 5 Gy. Melatonin with its 
antioxidant capacity protected against the hypoxic conditions of chondrocytes and 
promoted continued proliferation despite exposure to radiation. Moreover, in vitro studies 
showed that melatonin is capable of promoting osteoblast proliferation directly and 
stimulating these cells to produce increased amounts of several bone matrix proteins such as 
bone sialoprotein, alkaline phosphatase, osteocalcin (Roth et al. 1999) and procollagen type I 
c-peptide (Nakade et al. 1999), responsible for bone formation. Osteoprotegerin, an 
osteoblastic protein that inhibits the differentiation of osteoclasts is also increased by 
melatonin in vitro (Koyama et al. 2002). This data may support the radioprotective effect of 
melatonin on bone growth. The effects of fractionated radiotherapy combined with 
radioprotection by melatonin compared with fractionated radiotherapy alone in preserving 
the integrity and function of the epiphyseal growth plate from radiation damage in a 
weanling rat model was investigated. Data revealed that melatonin is more protective for 
bone growth protection than amifostine and a potential exists to implement the use of 
melatonin in an effort to maximize the radiotherapeutic management of children with less 
long-term morbidity than previous clinical experience (Yavuz et al. 2003). 
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Recent studies have documented that radiation in general and radiotherapy in particular 
has effects on brain function, such as thinking, memory and learning ability (Hsiao et al. 
2010). Because cognitive health of an organism is maintained by the ability of hippocampal 
precursors to proliferate and differentiate, radiation exposures have been shown to inhibit 
neurogenesis and are associated with the onset of cognitive impairments. In recent 
investigation, on the protection by melatonin against the delayed effects of cranial 
irradiation on hippocampal neurogenesis melatonin maintained adult hippocampal 
neurogenesis and cognitive functions after irradiation (Manda and Reiter 2010). In this 
study the pretreatment with melatonin showed a significantly higher count of microtubule 
binding protein doublecortin and the proliferation marker Ki-67 positive cells compared 
with irradiated only animals. The protection was achieved by a single intraperitoneal 
injection of 10 mg melatonin/kg bw prior to irradiation. These protective effects were 
accompanied by significant control of oxidative stress indicated by reduction in the count of 
immunohistochemical localization of DNA damage and lipid peroxidation using the anti-8-
hydroxy-2-deoxyguanosin the anti-hydroxynonenal. This indicated that melatonin minimize 
cell death. 
6.4 Melatonin modulates apoptosis in radiotherapy and space radiation 
Recent studies have showed the exposure to heavy ions such as 56Fe or 12C particle can induce 
detrimental physiological and histological changes in the brain, which lead to behavioral 
changes, spatial learning, and memory deficits. During space travel, astronauts are exposed to 
high-LET galactic cosmic rays at higher radiation doses and dose rates than humans received 
on Earth is one of the acknowledged showstoppers for long duration manned interplanetary 
missions. Hadrontherapy is an innovative modality of high precision tool for radiotherapy 
which consists in using hadrons (mainly protons or carbon ions) to irradiate tumors. This 
technique is used in certain cases to treat patients whose tumors are resistant to conventional 
X-ray radiotherapy. Given cancer therapy and space radiation protection, there is a demand 
for reliable agent for the protection of the brain against oxidative stress induced by heavy-ion 
radiation. It is well known that ionizing radiations can induce apoptosis. It is well known that 
oxidative stress is a mediator of apoptosis by compromising the fine balance between 
intracellular oxidant and their defense systems to produce abnormally high levels of ROS. 
Melatonin supplementation at 1,3&10mg/Kg bw reduced irradiation-induced oxidative 
damage, and stimulated the activities of SOD & CAT together with total antioxidant capacity 
in brain of rats exposed to heavy-ion radiation. Furthermore, pretreatment with melatonin 
significantly elevated the expression of Nrf2 which regulates redox balance and stress. In 
addition, pre-irradiation treatment with melatonin mitigated apoptotic rate, maintained 
mitochondrial membrane potential, decreased cytochrome C release from mitochondria, 
down-regulated Bax/Bcl-2 ratio and caspase-3 levels, and consequently inhibited the 
important steps of irradiation-induced activation of mitochondrial pathway of apoptosis (Liu 
et al. 2011). Studies performed by other investigators documented that melatonin pretreatment 
inhibited the cerebellum cell apoptosis after mice received 2 Gy 56Fe particle irradiation 
(Manda and Reiter 2010) and that decreased apoptosis by melatonin was associated with a 
reduction in Bax/Bcl-2 ratio in mice splenocytes exposed to 2 Gy X-ray irradiation (Jang et al. 
2009). Along this line, melatonin supplementation suppresses NO-induced apoptosis via 
induction of Bcl-2 expression in immortalized pineal PGT-ǃ cells (Yim et al. 2002). A similar 
pathway of inhibitory effects of melatonin on apoptosis induced by ischemic neuronal injury 
has been determined (Sun et al. 2002).  
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Relevant to this context, it has been recently proposed that ERK MAPK plays a central role 
to determine whether cells will live or die in response to apoptotic stimuli. It is well 
documented that the apoptotic signaling activated during UVB stress mainly converges at 
the mitochondrial level into intrinsic pathway and supporting evidence consider this 
pathway might be the principle target of melatonin to prevent apoptosis in human 
leukocytes (Radogna et al. 2008) as well as in other tumor cell lines and in vivo models 
(Acuna-Castroviejo et al. 2007). An in vitro stress model for the cell protection and 
antiapoptotic functions of melatonin was studied using U937 cells exposed to UVB radiation 
(Luchetti et al. 2006). Melatonin sustained the activation of the survival-promoting pathway 
ERK MAPK (extracellular signal-regulated kinase) which controls the balance between 
survival and death-promoting genes throughout the MAPK pathway, and is required to 
antagonize UVB induced apoptosis of U937 cells. This kinase was found to modulate the 
antioxidant and mitochondrial protection effects of melatonin that may find therapeutic 
applications in inflammatory and immune diseases associated with leukocyte oxidative 
stress and accelerated apoptosis (Luchetti et al. 2009, Luchetti et al. 2006). Recently, it is 
reported that redox-sensitive components are included in the cell protection signaling of 
melatonin and in the resulting transcriptional response that involves the control of NF-κB, 
AP-1, and Nrf2. Through these pathways, melatonin stimulates the expression of 
antioxidant and detoxification genes, acting in turn as a glutathione system promoter 
(Luchetti et al. 2010). 
It is suggested that ionizing radiation produces oxidative stress due formation of 
mitochondrial ROS resulting in calcium influx into the mitochondria with opening of the 
mitochondrial permeability transition pore (MPTP) (Andrabi et al. 2004, Halestrap 2006) and 
depolarization of the mitochondrial membrane potential as the end result of radiation-
induced mitochondrial damage and cell apoptosis. The different regulatory mechanisms of 
apoptosis and their modification by treatment with melatonin were tested in different cells 
after irradiation. It is found that the mitochondrial pathway was strongly influenced by 
melatonin by reducing mitochondrial ROS generation and calcium release as well as 
inhibiting the opening of the MPTP as shown in rat brain astrocytes (Jou et al. 2004), mouse 
striatal neurons (Andrabi et al. 2004) and rat cerebellar granule neurons (Han et al. 2006). 
Moreover, the prevented decreases in the mitochondrial membrane potential resulted from 
irradiation suggests that melatonin, due to its physiochmeical characters crosses the blood–
brain barrier and biological membranes to easily reach mitochondria, stabilizes oxidative 
stress-mediated dysfunction and integrity of mitochondria by preserving its membrane 
potential and increasing the efficiency of mitochondrial electron transfer chain and ATP 
synthesis (Acuna-Castroviejo et al. 2001). When melatonin treated cultured keratinocytes 
were irradiated with UVB radiation (50 mJ/cm2), there were less cell leaky, more uniform 
shape and less nuclear condensation as compared to irradiated, nonmelatonin-treated 
controls (Fischer et al. 2006). Exogenous melatonin with its anti-apoptotic and antioxidant 
properties additively increased the immunity of the animals, by protecting their 
hematopoietic system and lymphoid organs against X-ray radiation induced cellular toxicity 
(Sharma et al. 2008). These findings strongly highlight melatonin as a potential 
antiaopoptotic neuroprotective and mitigative agent against the space radiation hazards and 
the side effect risk in hadrontherapy. Consistent with all the overwhelming experimental 
evidence described above it may be concluded that melatonin can efficiently protect against 
and mitigate radiation induced oxidative stress. The majority of the published works on its 
ROS scavenging action coincide on the conclusion that melatonin is excellent for this task 
and make melatonin efficient pharmacological radioprotectors.  
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7. Toxicity and biosafety of melatonin 
The melatonin doses chosen in several studies were between 5 and 15 mg/kg bw, which are 
rather minimal effective doses as reported in animal studies. Whereas, pharmacological 
studies in rats of up to 250 mg/kg doses did not indicate any adverse effects. In addition, 
human volunteers who ingested a single oral dose of 1–300 mg and 1 g of melatonin daily 
for 30 days did not report any adverse side effects. In a study, none of the 15 weanling rats 
administered with 5–15 mg/kg of melatonin died during the 6-wk observation period 
(Yavuz et al. 2003). In addition, ip treatment with melatonin for 45 days did not show 
abnormal singes (El-Missiry et al. 2007). All of these observations provide support for the 
non-toxic nature of melatonin (Cheung et al. 2006).  
8. Conclusion 
Apart from nuclear accidents, radiation has been used increasingly in medicine and 
industry to help with diagnosis, treatment, and technology. However, radiation hazards 
present an enormous challenge for the biological and medical safety. The deleterious effects 
of ionizing radiation in biological systems are mainly mediated through the generation ROS 
in cells as a result of water radiolysis leading to oxidative stress. OH considered the most 
damaging of all free radicals generated in organisms, are often responsible for biomolecular 
damage caused by ionizing radiation. Oxidative stress greatly contributes to radiation-
induced cytotoxicity and to metabolic and morphologic changes in animals and humans 
during occupational settings, radiotherapy, and space flight. Melatonin is an indoleamine 
hormone synthesized from tryptophan in pinealocytes. It is distributed ubiquitously in 
organisms and in all cellular compartments, and it easily passes through all biological 
membranes. Several studies have indicated that melatonin may act as a scavenger of ROS 
such as hydroxyl radical, alkoxyl radical, hypochlorous acid and singlet oxygen. A number 
of in vitro and in vivo studies have reported that exogenously administered melatonin 
provides protection against radiation induced oxidative stress in different species. Its ability 
to reduce DNA damage, lipid peroxidation, and protein damage may originate from its 
function as a preventive antioxidant (scavenging initiating radicals directly or indirectly). 
Furthermore, this indoleamine manifests its antioxidative properties by upregulation of 
endogenous antioxidant defense mechanisms, increases the efficiency of the electron 
transport chain thereby limiting electron leakage and free radical generation, protects the 
integrity of the mitochondria and promotes ATP synthesis. Furthermore, several metabolites 
that are formed when melatonin neutralizes damaging reactants are themselves scavengers 
suggesting scavenging cascade reaction that greatly increase the efficacy of melatonin in 
preventing oxidative damage. Several observations provide support for the non-toxic nature 
of melatonin. The radioprotective and mitigative effects of melatonin against cellular 
damage caused by oxidative stress and its low toxicity make this innate antioxidant a 
potential drug in situations where the effects of ionizing radiation are to be controlled.  
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